Novorapid is a brand of insulin analogs used to treat endocrine and metabolic disorders. It is a fast-acting insulin that is used to control blood sugar levels in people with diabetes. Novorapid is a recombinant human insulin analog that is produced by recombinant DNA technology. It is designed to act faster and more predictably than regular human insulin. It is used to treat both type 1 and type 2 diabetes. Novorapid is administered subcutaneously and is usually taken before meals. It is used to control postprandial glucose levels and to prevent long-term complications of diabetes. The Novorapid market is highly competitive, with several companies offering insulin analogs. These include Novo Nordisk, Eli Lilly, Sanofi, Merck, and Boehringer Ingelheim. Each company offers a range of insulin analogs, including Novorapid, to meet the needs of people with diabetes. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
